DOOR syndrome: deficiency of E1 component of the 2-oxoglutarate dehydrogenase complex

Sankar Surendran1, Kimberlee Michals-Matalon, Stephan Krywawych

  • 1Department of Pediatrics, University of Texas Medical Branch, Galveston, Texas 77555, USA.

Insights

This study identifies a key biochemical marker for DOOR syndrome. Reduced 2-oxoglutarate decarboxylase (E1(0)) activity in patients

Area of Science:

  • Genetics
  • Biochemistry
  • Rare Diseases

Background:

  • DOOR syndrome is a rare genetic disorder characterized by onycho-osteodystrophy, dystrophic thumbs, sensorineural deafness, and elevated urinary 2-oxoglutarate.
  • The autosomal recessive form of DOOR syndrome has been linked to metabolic disturbances, but a specific biochemical marker was lacking.

Purpose of the Study:

  • To investigate the role of 2-oxoglutarate decarboxylase (E1(0)) activity in patients with the autosomal recessive form of DOOR syndrome.
  • To determine if E1(0) deficiency can serve as a biochemical marker for this condition.

Main Methods:

  • Enzyme activity assays were performed on fibroblasts and white blood cells from four patients across three families diagnosed with DOOR syndrome.
  • Activity levels of 2-oxoglutarate decarboxylase (E1(0)) were compared between patients and healthy controls.

Main Results:

  • Significantly decreased activity of 2-oxoglutarate decarboxylase (E1(0)) was observed in the fibroblasts and white blood cells of all DOOR syndrome patients.
  • E1(0) activity in patients was markedly lower compared to control subjects.

Conclusions:

  • This study establishes that E1(0) deficiency is a significant biochemical marker for the autosomal recessive form of DOOR syndrome.
  • Identifying E1(0) deficiency aids in the diagnosis and understanding of the metabolic basis of DOOR syndrome.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Protein Import into the Peroxisomes01:27

Protein Import into the Peroxisomes

Cells contain membrane-bound organelles called peroxisomes that oxidize organic molecules by transferring hydrogen atoms to oxygen, producing hydrogen peroxide. Peroxisomes enzymatically convert the released hydrogen peroxide into water and oxygen.
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
Electron Transport Chain: Complex III and IV01:43

Electron Transport Chain: Complex III and IV

During the electron transport chain, electrons from NADH and FADH2 are first transferred to complexes I and II, respectively. These two complexes then transfer the electrons to ubiquinol, which carries them further to complex III. Complex III passes the electrons across the intermembrane space to Cyt c, which carries them further to complex IV. Complex IV donates electrons to oxygen and reduces it to water. As electrons pass through complexes I, III, and IV, the energy released aids the pumping...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...